Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...

But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Diabetes is a condition that arises when proper blood sugar control has become defective. This leads to abnormally high blood sugar levels.

Scottish nurse Susan McGowan felt unwell after administering her second injection of weight loss drug tirzepatide before she ...

It is thought to be the first death in the UK linked to the medication Mounjaro, nicknamed the ‘King Kong jab’ ...